Apollon Formularies Plc Notice of AGM

 
TIDMAPOL 
 
05 December 2023 
 
Apollon Formularies Plc 
 
("Apollon" or the "Company") 
 
Notice of AGM 
 
Apollon Formularies plc (AQSE: APOL) announces that notice of its Annual General 
Meeting ('AGM') has been posted to shareholders, and will shortly be available 
at the Company website on  https://www.apollon.org.uk/. The AGM will be held on 
29 December 2023 at 11am, at 6 Heddon Street, London W1B 4BT. 
 
The directors of the Company accept responsibility for the contents of this 
announcement. 
 
ENDS 
 
For additional information, please visit www.apollon.org.uk or contact: 
 
Apollon Formularies 
 
Tel:                                         +44 771 198 0221 
 
Stene Jacobs                      stene@apollon.org.uk 
 
Peterhouse Capital Limited (Corporate Adviser) 
 
Tel:                                         +44 207 220 9795 
 
Guy Miller                           gm@peterhousecapital.com 
 
About Apollon and Apollon Jamaica 
 
Apollon Formularies plc is an international medical cannabis and medicinal 
mushroom pharmaceutical company headquartered in the United Kingdom. Apollon 
Formularies Jamaica Limited is a pharmaceutical company incorporated and 
operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed 
by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate 
(R&D), perform research and development, process, and sell medical cannabis 
therapeutic products that include legal medical cannabis to treat various 
illnesses under medical supervision. 
 
 
This information was brought to you by Cision http://news.cision.com 
 
 
END

(END) Dow Jones Newswires

December 05, 2023 06:59 ET (11:59 GMT)

Apollon Formularies (AQSE:APOL)
Historical Stock Chart
From Apr 2024 to May 2024